Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000899243-22-038614)

Filing Details

Accession Number:: 0000899243-22-038614
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-12-15 16:44:40
Reporting Period:: 2022-12-14

Accepted Time:: 2022-12-15 16:44:40
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1463361	Unity Biotechnology Inc.	UBX	Pharmaceutical Preparations (2834)	264726035

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1734424	Jamie Dananberg	C/O Unity Biotechnology, Inc. 285 East Grand Avenue South San Francisco CA 94080	Chief Medical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, $0.0001 Par Value	Disposition	2022-12-14	1,016	$2.85	65,105	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

Shares sold by the Reporting Person pursuant to a Rule 10b5-1 trading instruction to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units.
Includes Restricted Stock Units which vest over time measured from the grant date.
Reflects a 1-for-10 reverse stock split of the Issuer's common stock, effected by the Issuer on October 19, 2022, which was exempt from reporting pursuant to Rule 16a-9.